CoChat

Bioengineered 3D models of human pancreatic cancer recapitulate in vivo tumour biology

Open access

The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.

Abstract

Patient-derived in vivo models of human cancer have become a reality, yet their turnaround time is inadequate for clinical applications. Therefore, tailored ex vivo models that faithfully recapitulate in vivo tumour biology are urgently needed. These may especially benefit the management of pancreatic ductal adenocarcinoma (PDAC), where therapy failure has been ascribed to its high cancer stem cell (CSC) content and high density of stromal cells and extracellular matrix (ECM). To date, these features are only partially reproduced ex vivo using organoid and sphere cultures. We have now developed a more comprehensive and highly tuneable ex vivo model of PDAC based on the 3D co-assembly of peptide amphiphiles (PAs) with custom ECM components (PA-ECM). These cultures maintain patient-specific transcriptional profiles and exhibit CSC functionality, including strong in vivo tumourigenicity. User-defined modification of the system enables control over niche-dependent phenotypes such as epithelial-to-mesenchymal transition and matrix deposition. Indeed, proteomic analysis of these cultures reveals improved matrisome recapitulation compared to organoids. Most importantly, patient-specific in vivo drug responses are better reproduced in self-assembled cultures than in other models. These findings support the use of tuneable self-assembling platforms in cancer research and pave the way for future precision medicine approaches.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-021-25921-9

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Design and characterisation of PA-ECM co-assembling matrices. a Schematic illustration of PA hydrogel co-assembly with ECM macromolecules compared to currently used substrates for the in vitro modelling of PDAC. b Transmission electron micrograph of PA fibres. Scale bar: 100 µm. c–e Scanning electron micrographs of PA hydrogels co-assembled with collagen (c), collagen and fibronectin (d) and all ECM components (e); insert indicates imaged area within a 2 µL hydrogel. Scale bar: 2 µm. Insert scale bar: 500 µm. f PA fibre size measured from TEM micrographs. Box plots indicate range, interquartile range and median. n = 20 individual fibres. g PA fibre circular dichroism spectrum in HEPES buffer. h Stiffness (Young’s modulus) of PDX tissue, as measured by atomic force microscopy (n = 71 measurements across a tissue section), compared to PA-ECM (n = 24 measurements of a 10 mg/mL gel) and Matrigel (n = 38 measurements of a 10 mg/mL gel), as measured by rheometry. Box plots indicate range, interquartile range and median. i Experimental outline for the validation of the platform as a model for pancreatic cancer.
Fig. 1 Design and characterisation of PA-ECM co-assembling matrices. a Schematic illustration of PA hydrogel co-assembly with ECM macromolecules compared to currently used substrates for the in vitro modelling of PDAC. b Transmission electron micrograph of PA fibres. Scale bar: 100 µm. c–e Scanning electron micrographs of PA hydrogels co-assembled with collagen (c), collagen and fibronectin (d) and all ECM components (e); insert indicates imaged area within a 2 µL hydrogel. Scale bar: 2 µm. Insert scale bar: 500 µm. f PA fibre size measured from TEM micrographs. Box plots indicate range, interquartile range and median. n = 20 individual fibres. g PA fibre circular dichroism spectrum in HEPES buffer. h Stiffness (Young’s modulus) of PDX tissue, as measured by atomic force microscopy (n = 71 measurements across a tissue section), compared to PA-ECM (n = 24 measurements of a 10 mg/mL gel) and Matrigel (n = 38 measurements of a 10 mg/mL gel), as measured by rheometry. Box plots indicate range, interquartile range and median. i Experimental outline for the validation of the platform as a model for pancreatic cancer.CC BY · PubMed Central
Fig. 2 PA-ECM cultures for the ex vivo modelling of pancreatic cancer. a Schematic illustration of 3D cell culture in PA-ECM. b Brightfield micrograph of PDAC cells co-cultured with PSCs and macrophages in PA-ECM; insert indicates imaged area within a 5 µL hydrogel. Scale bar: 50 µm. Insert scale bar: 500 µm. c Haematoxylin (blue) and eosin (red) stain of PA-ECM hydrogel triple culture. Scale bar: 50 µm. d 3D projection of PDAC cells grown in PA-ECM for 14 days. Living cells were stained with calcein AM (green) and dead cells with ethidium homodimer (red). Scale bar: 100 µm. e 3D projection of PDAC cells co-cultured with PSCs and macrophages in PA-ECM hydrogels for 7 days and stained for EpCAM (green) and Ki-67 (white). Scale bar: 100 µm. f–i 3D projection of a PA-ECM hydrogel triple culture. PDAC cells were identified by EpCAM (green)(f), PSCs by α-SMA (magenta) (g) and macrophages by CD68 (cyan) (h) immunostaining. All cell types are shown on (i). Scale bars: 50 µm.
Fig. 2 PA-ECM cultures for the ex vivo modelling of pancreatic cancer. a Schematic illustration of 3D cell culture in PA-ECM. b Brightfield micrograph of PDAC cells co-cultured with PSCs and macrophages in PA-ECM; insert indicates imaged area within a 5 µL hydrogel. Scale bar: 50 µm. Insert scale bar: 500 µm. c Haematoxylin (blue) and eosin (red) stain of PA-ECM hydrogel triple culture. Scale bar: 50 µm. d 3D projection of PDAC cells grown in PA-ECM for 14 days. Living cells were stained with calcein AM (green) and dead cells with ethidium homodimer (red). Scale bar: 100 µm. e 3D projection of PDAC cells co-cultured with PSCs and macrophages in PA-ECM hydrogels for 7 days and stained for EpCAM (green) and Ki-67 (white). Scale bar: 100 µm. f–i 3D projection of a PA-ECM hydrogel triple culture. PDAC cells were identified by EpCAM (green)(f), PSCs by α-SMA (magenta) (g) and macrophages by CD68 (cyan) (h) immunostaining. All cell types are shown on (i). Scale bars: 50 µm.CC BY · PubMed Central
Fig. 3 Transcriptomic analysis of ex vivo models of PDAC. a Hierarchically clustered distance matrix of the PDAC samples analysed by RNA sequencing. Distance is shown in colour-coded arbitrary units. b Regularised log2 expression of the top 20,000 genes expressed in all samples. c Volcano plot showing gene enrichment in primary tumours compared to PA-ECM monocultures, with correction for interpatient differences. d Heatmap depicting pathways identified by gene set enrichment analysis that are up- or downregulated in 3D models with respect to 2D monolayers. Normalised enrichment scores (NES) are colour-coded. e Correlation of epithelial and matrisome gene list expression between primary PDAC tissues and their corresponding organoids and PA-ECM cultures. Mean and range are shown for two biologically independent replicates per sample type. ORG organoids, SPH spheres, PRI primary tumours.
Fig. 3 Transcriptomic analysis of ex vivo models of PDAC. a Hierarchically clustered distance matrix of the PDAC samples analysed by RNA sequencing. Distance is shown in colour-coded arbitrary units. b Regularised log2 expression of the top 20,000 genes expressed in all samples. c Volcano plot showing gene enrichment in primary tumours compared to PA-ECM monocultures, with correction for interpatient differences. d Heatmap depicting pathways identified by gene set enrichment analysis that are up- or downregulated in 3D models with respect to 2D monolayers. Normalised enrichment scores (NES) are colour-coded. e Correlation of epithelial and matrisome gene list expression between primary PDAC tissues and their corresponding organoids and PA-ECM cultures. Mean and range are shown for two biologically independent replicates per sample type. ORG organoids, SPH spheres, PRI primary tumours.CC BY · PubMed Central
Fig. 4 CSC enrichment in PA-ECM cultures. a Expression of CSC factors by PDAC cells (12560) cultured in PA-ECM compared to 2D monolayers (mean ± SD; n = 3 biological replicates). b Percentage of CD133 + /CXCR4 + PDAC cells in PDX and ex vivo PDAC models as assayed by flow cytometry in three matched experiments (mean ± SD). c Number of spheres by size range formed by PDAC cells (12560) derived from PA-ECM cultures, primary spheres, organoids and 2D monolayers (mean ± SD; n = 3 biological replicates). d Engraftment rate of PA-ECM and organoid PDAC cultures (12560) implanted in nude mice (three mice with two tumours per condition). e Volume of tumours grown in nude mice from implanted PA-ECM and organoid cultures carrying increasing numbers of PDAC cells (12560) (three mice with two tumours per condition). Shaded areas denote standard deviation around mean. f Representative histology images of PDAC tissues derived from patient 12560, including primary tumour, patient-derived xenografts and tumours grown in nude mice from implanted PA-ECM and organoid cultures. Scale bars: 100 µm.
Fig. 4 CSC enrichment in PA-ECM cultures. a Expression of CSC factors by PDAC cells (12560) cultured in PA-ECM compared to 2D monolayers (mean ± SD; n = 3 biological replicates). b Percentage of CD133 + /CXCR4 + PDAC cells in PDX and ex vivo PDAC models as assayed by flow cytometry in three matched experiments (mean ± SD). c Number of spheres by size range formed by PDAC cells (12560) derived from PA-ECM cultures, primary spheres, organoids and 2D monolayers (mean ± SD; n = 3 biological replicates). d Engraftment rate of PA-ECM and organoid PDAC cultures (12560) implanted in nude mice (three mice with two tumours per condition). e Volume of tumours grown in nude mice from implanted PA-ECM and organoid cultures carrying increasing numbers of PDAC cells (12560) (three mice with two tumours per condition). Shaded areas denote standard deviation around mean. f Representative histology images of PDAC tissues derived from patient 12560, including primary tumour, patient-derived xenografts and tumours grown in nude mice from implanted PA-ECM and organoid cultures. Scale bars: 100 µm.CC BY · PubMed Central
Fig. 5 Control over PDAC cell phenotypes in PA hydrogels. a Gene expression of PDAC cells (12560) as a function of PA concentration relative to 2D controls (mean ± SD; n = 3 biological replicates). p values were calculated by two-way ANOVA with Bonferroni correction. b Percentage of vimentin-positive PDAC colonies (12560) as a function of PA concentration as quantified from immunofluorescence micrographs. Box plots indicate range, interquartile range and median (n = 8 biological replicates). p values were calculated by one-way ANOVA with Bonferroni correction. c Log2 normalised expression of PDAC cells (12560) grown in PA hydrogels assembled in different gelling conditions relative to the 2D baseline (mean ± SD; n = 3 biological replicates). p values were calculated by two-way ANOVA with Bonferroni correction. d Log2 normalised gene expression of PDAC cells (12560) cultured in PA hydrogels in sphere medium (SM) and PSC-conditioned medium (PCM) relative to the 2D SM baseline (mean ± SD; n = 3 biological replicates). p values were calculated by two-way ANOVA with Bonferroni correction. e Scratch closure of PDAC cells (12560) cells in the presence of hyaluronan. Box plots indicate range, interquartile range and median (n = 12 biological replicates in three experiments). f Log2 normalised invasion of PDAC cells (12560) across collagen-coated transwells as a function of the concentration of low (10 kDa) and high (1 MDa) molecular mass hyaluronan. Box plots indicate range, interquartile range and median (n = 42 biological replicates in 6 experiments). p values were calculated by one-way ANOVA with Bonferroni correction. g Number of spheres formed by PDAC cells (12560) as a function of the size and concentration of hyaluronan in the medium (mean ± SD; n = 6 biological replicates in three experiments). p values were calculated by two-way ANOVA with Bonferroni correction. h Brightfield images of PDAC cell colonies (12560) formed on low-attachment plates coated with collagen, with and without 10 kDa/1 MDa hyaluronan in the medium. Scale bars: 500 µm.
Fig. 5 Control over PDAC cell phenotypes in PA hydrogels. a Gene expression of PDAC cells (12560) as a function of PA concentration relative to 2D controls (mean ± SD; n = 3 biological replicates). p values were calculated by two-way ANOVA with Bonferroni correction. b Percentage of vimentin-positive PDAC colonies (12560) as a function of PA concentration as quantified from immunofluorescence micrographs. Box plots indicate range, interquartile range and median (n = 8 biological replicates). p values were calculated by one-way ANOVA with Bonferroni correction. c Log2 normalised expression of PDAC cells (12560) grown in PA hydrogels assembled in different gelling conditions relative to the 2D baseline (mean ± SD; n = 3 biological replicates). p values were calculated by two-way ANOVA with Bonferroni correction. d Log2 normalised gene expression of PDAC cells (12560) cultured in PA hydrogels in sphere medium (SM) and PSC-conditioned medium (PCM) relative to the 2D SM baseline (mean ± SD; n = 3 biological replicates). p values were calculated by two-way ANOVA with Bonferroni correction. e Scratch closure of PDAC cells (12560) cells in the presence of hyaluronan. Box plots indicate range, interquartile range and median (n = 12 biological replicates in three experiments). f Log2 normalised invasion of PDAC cells (12560) across collagen-coated transwells as a function of the concentration of low (10 kDa) and high (1 MDa) molecular mass hyaluronan. Box plots indicate range, interquartile range and median (n = 42 biological replicates in 6 experiments). p values were calculated by one-way ANOVA with Bonferroni correction. g Number of spheres formed by PDAC cells (12560) as a function of the size and concentration of hyaluronan in the medium (mean ± SD; n = 6 biological replicates in three experiments). p values were calculated by two-way ANOVA with Bonferroni correction. h Brightfield images of PDAC cell colonies (12560) formed on low-attachment plates coated with collagen, with and without 10 kDa/1 MDa hyaluronan in the medium. Scale bars: 500 µm.CC BY · PubMed Central
Fig. 6 Core matrisome recapitulation in PDX, PA-ECM and organoid models. a Heatmap of the top matrisome proteins detected which fall on or above the 90th percentile rank in abundance (mean across all patients) in at least one of the sample categories. For the PDX and Matrigel samples, abundance was calculated as the sum of the human and murine peptides. Those proteins for which >50% of the peptides detected were of murine origin are indicated with an asterisk. b Distribution of interstitial collagen chains and laminin trimers for all sample categories. Data correspond to the mean across all patients.
Fig. 6 Core matrisome recapitulation in PDX, PA-ECM and organoid models. a Heatmap of the top matrisome proteins detected which fall on or above the 90th percentile rank in abundance (mean across all patients) in at least one of the sample categories. For the PDX and Matrigel samples, abundance was calculated as the sum of the human and murine peptides. Those proteins for which >50% of the peptides detected were of murine origin are indicated with an asterisk. b Distribution of interstitial collagen chains and laminin trimers for all sample categories. Data correspond to the mean across all patients.CC BY · PubMed Central
Fig. 7 In vivo and ex vivo PDAC matrisome analysis. a Scatter plot showing the total abundance and number of proteins of each matrisome category for each primary tumour analysed. b Principal component analysis of the core matrisome datasets from patients 12556, 12559, 12560, 12707 and 12975. c Scatter plot showing the correlation between the number of proteins of the primary core matrisomes and those of their corresponding PDX, PA-ECM and organoid models. The PDX murine baseline indicates the number of murine ECM proteins predicted to reside at the site of PDX implantation. d Percentage of matrisome peptides detected in the PDX and organoid samples which are of human, mouse or common origin. Common peptides are identical in both species. e Colour-coded correlation between the core matrisome protein abundances in primary tumours and their corresponding PDX, PA-ECM and organoid models. R is the correlation coefficient.
Fig. 7 In vivo and ex vivo PDAC matrisome analysis. a Scatter plot showing the total abundance and number of proteins of each matrisome category for each primary tumour analysed. b Principal component analysis of the core matrisome datasets from patients 12556, 12559, 12560, 12707 and 12975. c Scatter plot showing the correlation between the number of proteins of the primary core matrisomes and those of their corresponding PDX, PA-ECM and organoid models. The PDX murine baseline indicates the number of murine ECM proteins predicted to reside at the site of PDX implantation. d Percentage of matrisome peptides detected in the PDX and organoid samples which are of human, mouse or common origin. Common peptides are identical in both species. e Colour-coded correlation between the core matrisome protein abundances in primary tumours and their corresponding PDX, PA-ECM and organoid models. R is the correlation coefficient.CC BY · PubMed Central
Fig. 8 PDAC treatment response in PA-ECM and organoid cultures. a Histology of PDAC (12560) mono- and triple cultures in PA-ECM treated with gemcitabine/nab-paclitaxel. Cells were stained with H&E to assess cellularity, Ki-67 for proliferation and cleaved caspase-3 for apoptosis. Scale bars: 100 µm. b In vivo response of PDX tumours to chemotherapy depicted as percentage of tumour volume post-treatment relative to controls (0.9% NaCl). Box plots indicate range, interquartile range and median. For each patient and condition, n = 5 mice with one tumour each. c Quantification of Ki-67 and cleaved caspase-3 staining of PDAC mono- and triple cultures in PA-ECM treated with gemcitabine/nab-paclitaxel. Triple+ cultures contained twice the number of PSCs (mean ± SD; n = 3 biological replicates). d Response of PA-ECM and organoid cultures to gemcitabine/nab-paclitaxel as assayed by flow cytometry. Percentages represent the proportion of cells that were both intact and in G1 phase compared to untreated controls (mean ± SD; n = 5 biological replicates). e, f Flow cytometry plots showing the cell cycle arrest of PA-ECM (e) and organoid (f) cultures treated with gemcitabine/nab-paclitaxel. The upper panels show the gated populations of intact cells. The lower panels depict the cell cycle profiles of untreated (red) and treated (blue) samples gated to exclude debris and doublets.
Fig. 8 PDAC treatment response in PA-ECM and organoid cultures. a Histology of PDAC (12560) mono- and triple cultures in PA-ECM treated with gemcitabine/nab-paclitaxel. Cells were stained with H&E to assess cellularity, Ki-67 for proliferation and cleaved caspase-3 for apoptosis. Scale bars: 100 µm. b In vivo response of PDX tumours to chemotherapy depicted as percentage of tumour volume post-treatment relative to controls (0.9% NaCl). Box plots indicate range, interquartile range and median. For each patient and condition, n = 5 mice with one tumour each. c Quantification of Ki-67 and cleaved caspase-3 staining of PDAC mono- and triple cultures in PA-ECM treated with gemcitabine/nab-paclitaxel. Triple+ cultures contained twice the number of PSCs (mean ± SD; n = 3 biological replicates). d Response of PA-ECM and organoid cultures to gemcitabine/nab-paclitaxel as assayed by flow cytometry. Percentages represent the proportion of cells that were both intact and in G1 phase compared to untreated controls (mean ± SD; n = 5 biological replicates). e, f Flow cytometry plots showing the cell cycle arrest of PA-ECM (e) and organoid (f) cultures treated with gemcitabine/nab-paclitaxel. The upper panels show the gated populations of intact cells. The lower panels depict the cell cycle profiles of untreated (red) and treated (blue) samples gated to exclude debris and doublets.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 70 references

Cited by

See all 153

Metadata

Authors
Osuna de la Peña, D., Trabulo, S. M. D., Collin, E., Liu, Y., Sharma, S., Tatari, M., Behrens, D., Erkan, M., Lawlor, R. T., Scarpa, A., Heeschen, C., Mata, A., & Loessner, D.
Affiliations
  • Queen Mary University of London (GB)
  • University of London (GB)
  • Koç University (TR)
  • University of Verona (IT)
  • Shanghai Jiao Tong University (CN)
Corresponding author
  • Heeschen, Christopher
  • Loessner, Daniela
Venue
Nature Communications
Published
2021-09-24
Volume
12
Issue
1
Pages
5623-5623
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3200665948
Cited by
138
References
70
Citations by year
2026: 23 · 2025: 26 · 2024: 32 · 2023: 32 · 2022: 16 · 2021: 8
FWCI
8.00
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Repository@Nottingham (University of Nottingham) (publishedVersion, cc-by)
  • Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
  • Digital Collections portal (Koç University) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • UCL Discovery (University College London) (submittedVersion)
Funders
EC | EC Seventh Framework Programm | FP7 Health (602783)
Topics
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
pancreatic ductal adenocarcinoma, peptide amphiphiles, extracellular matrix, cancer stem cells, epithelial-mesenchymal transition, matrisome, tumor stroma, drug response prediction, precision medicine, organoids
MeSH terms
Humans, Models, Biological, Pancreatic Neoplasms, Tumor Cells, Cultured, Neoplastic Stem Cells, Reproducibility of Results, Gene Expression Regulation, Neoplastic, Stromal Cells, Cell Culture Techniques, Gene Expression Profiling, Carcinoma, Pancreatic Ductal, Bioengineering

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bioengineered 3D models of human pancreatic cancer recapitulate in vivo tumour biology. https://app.cochat.ai/papers/10.1038/s41467-021-25921-9
The paper
Osuna de la Peña, D., Trabulo, S. M. D., Collin, E., Liu, Y., Sharma, S., Tatari, M., Behrens, D., Erkan, M., Lawlor, R. T., Scarpa, A., Heeschen, C., Mata, A., & Loessner, D. (2021). Bioengineered 3D models of human pancreatic cancer recapitulate in vivo tumour biology. Nature Communications. https://doi.org/10.1038/s41467-021-25921-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.